ArticleJournal for immunotherapy of cancer2025

PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment.

Céline Godfroid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.